We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.67B
AUM Growth
-$82.5M
Cap. Flow
-$148M
Cap. Flow %
-8.88%
Top 10 Hldgs %
45.8%
Holding
40
New
3
Increased
13
Reduced
11
Closed
6

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$77.4M
2
GILD icon
Gilead Sciences
GILD
+$65.2M
3
LH icon
Labcorp
LH
+$57.2M
4
ADNT icon
Adient
ADNT
+$34.5M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 43.23%
2 Consumer Discretionary 12.17%
3 Technology 7.33%
4 Financials 7.17%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$104M 6.23%
2,808,954
+347,714
+14% +$12.8M
POST icon
2
Post Holdings
POST
$4.17B
$102M 6.13%
1,772,202
-19,326
-1% -$1.06M
GDDY icon
3
GoDaddy
GDDY
$10.5B
$88.6M 5.31%
2,036,589
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$77.9M 4.66%
555,120
+349,114
+169% +$47.4M
CZR icon
5
Caesars Entertainment
CZR
$6.05B
$69.1M 4.14%
2,695,132
SGI
6
Somnigroup International
SGI
$14B
$67.4M 4.03%
4,177,348
-764,824
-15% -$11.3M
WMGI
7
DELISTED
Wright Medical Group Inc
WMGI
$66.1M 3.96%
2,554,894
+639,818
+33% +$17.6M
AWI icon
8
Armstrong World Industries
AWI
$7.31B
$64.1M 3.84%
1,251,456
TGTX icon
9
TG Therapeutics
TGTX
$8.01B
$62.7M 3.76%
5,295,044
+649,779
+14% +$7.4M
XBI icon
10
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.94B
$62.4M 3.74%
+721,000
New +$57.8M
AET
11
DELISTED
Aetna Inc
AET
$61.4M 3.68%
386,100
+41,691
+12% +$6.51M
AGN
12
DELISTED
Allergan plc
AGN
$58.6M 3.51%
286,002
+63,106
+28% +$14.7M
MS icon
13
Morgan Stanley
MS
$334B
$58.3M 3.49%
1,210,359
NKTR icon
14
Nektar Therapeutics
NKTR
$2.37B
$54.6M 3.27%
151,644
-35,762
-19% -$11.2M
HUM icon
15
Humana
HUM
$44.5B
$54.2M 3.25%
222,490
+8,154
+4% +$2M
ZBH icon
16
Zimmer Biomet
ZBH
$18B
$50.8M 3.04%
446,935
+31,682
+8% +$3.66M
MRK icon
17
Merck
MRK
$322B
$50.4M 3.02%
825,297
-4,613
-0.6% -$280K
MGM icon
18
MGM Resorts International
MGM
$11.4B
$49.6M 2.97%
1,523,332
+485,397
+47% +$15.6M
EVHC
19
DELISTED
Envision Healthcare Holdings Inc
EVHC
$49.2M 2.95%
1,094,194
-242,285
-18% -$12.9M
ALNY icon
20
Alnylam Pharmaceuticals
ALNY
$27.3B
$45.1M 2.7%
383,933
-375,194
-49% -$32M
CHTR icon
21
Charter Communications
CHTR
$17.2B
$42.2M 2.53%
116,109
-21,978
-16% -$8.18M
IRWD icon
22
Ironwood Pharmaceuticals
IRWD
$680M
$40.2M 2.4%
3,040,037
+1,684,513
+124% +$23.2M
META icon
23
Meta Platforms (Facebook)
META
$1.39T
$38.7M 2.32%
226,328
-95,177
-30% -$15.9M
INCY icon
24
Incyte
INCY
$24.3B
$36.8M 2.2%
315,262
-52,772
-14% -$6.68M
LBRDA icon
25
Liberty Broadband Class A
LBRDA
$4.87B
$36.8M 2.2%
390,292

Similar funds

Bridger Management's Q3 2017 Portfolio in Review

As of Q3 2017, Bridger Management held 40 positions worth $1.67B, down 4.7% from $1.75B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Bridger Management withdrew a net $148M in Q3 2017, closing 6 positions and reducing 11 holdings. Its most notable exit was Shire pic, an estimated $77.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 51% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Bridger Management opened a new position in Coterra Energy worth $24.6M.

  • Bridger Management's largest Q3 2017 buy was Coterra Energy: 919,090 shares worth $24.6M.
  • Bridger Management added most to Alexion Pharmaceuticals in Q3 2017, an estimated $47.4M increase.
  • Bridger Management's biggest Q3 2017 reduction was Alnylam Pharmaceuticals, cutting an estimated $32M.
  • Bridger Management fully exited Shire pic in Q3 2017, selling an estimated $77.4M.
  • Bridger Management's ten largest holdings make up 46% of its $1.67B portfolio in Q3 2017.
  • Bridger Management opened 3 new positions and closed 6 in Q3 2017.
  • Bridger Management's portfolio value fell 4.7% quarter-over-quarter to $1.67B.

Based on Bridger Management's 13F filing for Q3 2017, filed 14 Nov 2017.